Literature DB >> 18613267

Bringing the bedside to the bench, and then to the community: a prospectus for intervention research in late-life anxiety disorders.

Eric J Lenze1, Julie Loebach Wetherell.   

Abstract

BACKGROUND: Anxiety disorders are highly prevalent in elderly persons, and they are associated with functional impairment, poorer quality of life, and adverse long-term consequences such as cognitive decline. Intervention research in late-life anxiety disorders (LLAD) lags behind where it ought to be. Research in cognitive neuroscience, aging, and stress intersects in LLAD and provides the opportunity to develop innovative interventions to prevent chronic anxiety and its consequences in this age group.
METHODS: This paper evaluates gaps in the evidence base for treatment of LLAD and synthesizes recent research in cognitive neuroscience, basic behavioral science, stress, and aging.
RESULTS: We examine three intervention issues in LLAD: (1) prevention; (2) acute treatment; and (3) pre-empting adverse consequences. We propose combining randomized controlled trials (RCTs) with mechanistic biobehavioral methodologies as an optimal approach for developing novel, optimized, and personalized treatments. Additionally, we examine three barriers in the field of LLAD research: (1) How do we measure anxiety?; (2) How do we raise awareness?; (3) How will we ensure our research is applicable to underserved populations (particularly minority groups)?
CONCLUSIONS: This prospectus outlines approaches for intervention research that can reduce the morbidity of LLAD. (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 18613267      PMCID: PMC3635100          DOI: 10.1002/gps.2074

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  127 in total

1.  Measuring mood and complex behavior in natural environments: use of ecological momentary assessment in pediatric affective disorders.

Authors:  David A Axelson; Michele A Bertocci; Daniel S Lewin; Laura S Trubnick; Boris Birmaher; Douglas E Williamson; Neal D Ryan; Ronald E Dahl
Journal:  J Child Adolesc Psychopharmacol       Date:  2003       Impact factor: 2.576

2.  Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease.

Authors:  Kim N Green; Lauren M Billings; Benno Roozendaal; James L McGaugh; Frank M LaFerla
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

3.  Treatment of generalized anxiety disorder in older adults.

Authors:  Julie Loebach Wetherell; Margaret Gatz; Michelle G Craske
Journal:  J Consult Clin Psychol       Date:  2003-02

4.  Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging.

Authors:  Naomi M Simon; Jordan W Smoller; Kate L McNamara; Richard S Maser; Alyson K Zalta; Mark H Pollack; Andrew A Nierenberg; Maurizio Fava; Kwok-Kin Wong
Journal:  Biol Psychiatry       Date:  2006-04-11       Impact factor: 13.382

5.  Assessing worry in older adults: confirmatory factor analysis of the Penn State Worry Questionnaire and psychometric properties of an abbreviated model.

Authors:  Derek R Hopko; Melinda A Stanley; Deborah L Reas; Julie Loebach Wetherell; J Gayle Beck; Diane M Novy; Patricia M Averill
Journal:  Psychol Assess       Date:  2003-06

6.  Long-term immune-endocrine effects of bereavement: relationships with anxiety levels and mood.

Authors:  Gilberto Gerra; Daniela Monti; Alberto E Panerai; Paola Sacerdote; Roberta Anderlini; Paola Avanzini; Amir Zaimovic; Francesca Brambilla; Claudio Franceschi
Journal:  Psychiatry Res       Date:  2003-12-01       Impact factor: 3.222

7.  Age-related differences in brain activation during emotional face processing.

Authors:  Faith M Gunning-Dixon; Ruben C Gur; Alexis C Perkins; Lee Schroeder; Travis Turner; Bruce I Turetsky; Robin M Chan; James W Loughead; David C Alsop; Joseph Maldjian; Raquel E Gur
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

8.  Anxiety disorder and accompanying subjective memory loss in the elderly as a predictor of future cognitive decline.

Authors:  Gary Sinoff; Perla Werner
Journal:  Int J Geriatr Psychiatry       Date:  2003-10       Impact factor: 3.485

9.  Comorbidity and risk-patterns of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study.

Authors:  R A Schoevers; A T F Beekman; D J H Deeg; C Jonker; W van Tilburg
Journal:  Int J Geriatr Psychiatry       Date:  2003-11       Impact factor: 3.485

10.  Standard and enhanced cognitive-behavior therapy for late-life generalized anxiety disorder: two pilot investigations.

Authors:  Jan Mohlman; Ethan E Gorenstein; Marc Kleber; Marybeth de Jesus; Jack M Gorman; Lazlo A Papp
Journal:  Am J Geriatr Psychiatry       Date:  2003 Jan-Feb       Impact factor: 4.105

View more
  25 in total

1.  Augmenting antidepressant medication with modular CBT for geriatric generalized anxiety disorder: a pilot study.

Authors:  Julie Loebach Wetherell; Jill A Stoddard; Kamila S White; Sander Kornblith; Hoang Nguyen; Carmen Andreescu; Sidney Zisook; Eric J Lenze
Journal:  Int J Geriatr Psychiatry       Date:  2010-09-27       Impact factor: 3.485

2.  Emotion Reactivity and Cerebrovascular Burden in Late-Life GAD: A Neuroimaging Study.

Authors:  Helmet Karim; Dana Larisa Tudorascu; Howard Aizenstein; Sarah Walker; Rachel Good; Carmen Andreescu
Journal:  Am J Geriatr Psychiatry       Date:  2016-07-21       Impact factor: 4.105

3.  Psychotherapy for depression with executive dysfunction.

Authors:  Julie Loebach Wetherell
Journal:  Am J Psychiatry       Date:  2010-11       Impact factor: 18.112

4.  Treatment-related alteration of cortisol predicts change in neuropsychological function during acute treatment of late-life anxiety disorder.

Authors:  Eric J Lenze; David Dixon; Rose C Mantella; Peter M Dore; Carmen Andreescu; Charles F Reynolds; John W Newcomer; Meryl A Butters
Journal:  Int J Geriatr Psychiatry       Date:  2011-06-17       Impact factor: 3.485

5.  Changes in neuropsychological functioning following treatment for late-life generalised anxiety disorder.

Authors:  Meryl A Butters; Rishi K Bhalla; Carmen Andreescu; Julie Loebach Wetherell; Rose Mantella; Amy E Begley; Eric J Lenze
Journal:  Br J Psychiatry       Date:  2011-07-04       Impact factor: 9.319

6.  When the "Golden Years" Turn Blue: Using the Healthy Aging Literature to Elucidate Anxious and Depressive Disorders in Older Adulthood.

Authors:  Jennifer S Green; Joshua C Magee; Amanda R W Steiner; Bethany A Teachman
Journal:  Int J Behav Dev       Date:  2015-10-27

Review 7.  Innovations in research for treatment of late-life anxiety.

Authors:  Srijana Shrestha; Suzanne Robertson; Melinda A Stanley
Journal:  Aging Ment Health       Date:  2011-06-27       Impact factor: 3.658

8.  Predictors of change in quality of life in older adults with generalized anxiety disorder.

Authors:  Srijana Shrestha; Melinda A Stanley; Nancy L Wilson; Jeffrey A Cully; Mark E Kunik; Diane M Novy; Howard M Rhoades; Amber B Amspoker
Journal:  Int Psychogeriatr       Date:  2014-12-12       Impact factor: 3.878

9.  Evaluation of the factor structure and psychometric properties of the Brief Symptom Inventory-18 with homebound older adults.

Authors:  Andrew J Petkus; Amber M Gum; Brent Small; Vanessa L Malcarne; Murray B Stein; Julie Loebach Wetherell
Journal:  Int J Geriatr Psychiatry       Date:  2010-06       Impact factor: 3.485

10.  Emotion reactivity and regulation in late-life generalized anxiety disorder: functional connectivity at baseline and post-treatment.

Authors:  Carmen Andreescu; Lei K Sheu; Dana Tudorascu; James J Gross; Sarah Walker; Layla Banihashemi; Howard Aizenstein
Journal:  Am J Geriatr Psychiatry       Date:  2014-05-17       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.